Literature DB >> 2178009

Injection of alcohol to control bleeding from ruptured hepatomas.

S C Chung1, T W Lee, S P Kwok, A K Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2178009      PMCID： PMC1663669          DOI： 10.1136/bmj.301.6749.421

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Transcatheter arterial embolization for spontaneous rupture of hepatocellular carcinoma.

Authors:  K Hirai; Y Kawazoe; K Yamashita; M Kumagai; K Nagata; S Kawaguchi; M Abe; K Tanikawa
Journal:  Am J Gastroenterol       Date:  1986-04       Impact factor: 10.864

2.  Spontaneous rupture of hepatocellular carcinoma.

Authors:  G B Ong; J L Taw
Journal:  Br Med J       Date:  1972-10-21

3.  Spontaneous rupture of primary hepatoma: report of 63 cases with particular reference to the pathogenesis and rationale treatment by hepatic artery ligation.

Authors:  O Chearanai; U Plengvanit; C Asavanich; D Damrongsak; K Sindhvananda; S Boonyapisit
Journal:  Cancer       Date:  1983-04-15       Impact factor: 6.860

4.  Endoscopic hemostasis of bleeding of the upper gastrointestinal tract by local injection of ninety-eight per cent dehydrated ethanol.

Authors:  C Sugawa; Y Fujita; T Ikeda; A J Walt
Journal:  Surg Gynecol Obstet       Date:  1986-02
  4 in total
  3 in total

1.  Spontaneous hepatic rupture due to metastatic malignant melanoma.

Authors:  M Welch
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

2.  Spontaneous rupture of hepatocellular carcinoma with haemoperitoneum: a rare condition in Western countries.

Authors:  A D Chedid; P W Klein; M F Tiburi; M M Villwock; L E Bassani; M F Chedid
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

3.  Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection.

Authors:  Ana Castro-Balado; Cristina Mondelo-García; Letricia Barbosa-Pereira; Iria Varela-Rey; Ignacio Novo-Veleiro; Néstor Vázquez-Agra; José Ramón Antúnez-López; Enrique José Bandín-Vilar; Raquel Sendón-García; Manuel Busto-Iglesias; Ana Rodríguez-Bernaldo de Quirós; Laura García-Quintanilla; Miguel González-Barcia; Irene Zarra-Ferro; Francisco J Otero-Espinar; David Rey-Bretal; José Ramón Lago-Quinteiro; Luis Valdés-Cuadrado; Carlos Rábade-Castedo; María Carmen Del Río-Garma; Carlos Crespo-Diz; Olga Delgado-Sánchez; Pablo Aguiar; Gema Barbeito-Castiñeiras; María Luisa Pérez Del Molino-Bernal; Rocío Trastoy-Pena; Rossana Passannante; Jordi Llop; Antonio Pose-Reino; Anxo Fernández-Ferreiro
Journal:  Pharmaceutics       Date:  2021-03-05       Impact factor: 6.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.